Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable

Journal of Neuroscience

Volumn 22, Issue 24, 2002, Pages 10627-10632

  Matsui, Minoru ^a   Motomura, Daisuke ^a   Fujikawa, Toru ^b   Jiang, Jian ^b   Takahashi, Shin ichi ^a   Manabe, Toshiya ^a   Taketo, Makoto M ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Gene targeting; Intestinal motility; Muscarinic receptors; Ocular pupils; Smooth muscle contraction

Indexed keywords

MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; CARBACHOL; MUSCARINIC RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER DISTENSION; CELL VIABILITY; CHOLINERGIC SYSTEM; DETRUSOR MUSCLE; ELECTROSTIMULATION; EMBRYO; FEMALE; FERTILITY; GASTROINTESTINAL MOTILITY; GENE TARGETING; ILEUM; MALE; MICTURITION; MOUSE; MYDRIASIS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; ANIMAL; DIGESTIVE SYSTEM; DRUG EFFECT; GENETICS; HISTOLOGY; MIOSIS; MOUSE MUTANT; MUSCLE CONTRACTION; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PUPIL; SEX DIFFERENCE; SMOOTH MUSCLE; SURVIVAL; URINE RETENTION;

ANIMALS; CARBACHOL; DIGESTIVE SYSTEM; ELECTRIC STIMULATION; FEMALE; GENE TARGETING; MALE; MICE; MICE, KNOCKOUT; MIOSIS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENOTYPE; PUPIL; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; SEX FACTORS; SURVIVAL ANALYSIS; URINARY RETENTION;

EID: 0037114189     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-24-10627.2002     Document Type: Article

References (47)

1. Andersson KE (1998) The importance of the cholinergic system in neurourology. Eur Urol 34:6-9.
2. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
3. Bognar IT, Wesner MT, Fuder H (1990) Muscarine receptor types mediating autoinhibition of acetylcholine release and sphincter contraction in the guinea-pig iris. Naunyn Schmiedebergs Arch Pharmacol 341:22-29.
4. Boschero AC, Szpak-Glasman M, Carneiro EM, Bordin S, Paul I, Rojas E, Atwater I (1995) Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors. Am J Physiol 268:E336-E342.
5. Burnstock G, Dumsday B, Smythe A (1972) Atropine-resistant excitation of the urinary bladder: Possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol 44:451-461.
6. Calignano A, Capasso A, Persico P, Mancuso F, Sorrentino L (1992) Dexamethasone modifies morphine-, atropine-, verapamil-induced constipation in mice. Gen Pharmacol 23:753-756.
7. Caulfield MP, Birdsall NJM (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290.
8. Choppin A, Stepan GJ, Loury DN, Watson N, Eglen RM (1999) Characterization of the muscarinic receptor in isolated uterus of sham operated and ovariectomized rats. Br J Pharmacol 127:1551-1558.
9. de Groat WC, Yoshimura N (2001) Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol 41:691-721.
10. Eglen RM (2001) Muscarinic receptors and gastrointestinal tract smooth muscle function. Life Sci 68:2573-2578.
11. Eglen RM, Michel AD, Whiting RL (1989) Characterization of the muscarinic receptor subtype mediating contractions of the guinea-pig uterus. Br J Pharmacol 96:497-499.
12. Eglen RM, Choppin A, Watson N (2001) Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci 22:409-414.
13. Ehlert FJ, Sawyer GW, Esqueda EE (1999) Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle. Life Sci 64:387-394.
14. Furness JB (2000) Types of neurons in the enteric nervous system. J Auton Nerv Syst 81:87-96.
15. Giglio D, Delbro DS, Tobin G (2001) On the functional role of muscarinic M(2) receptors in cholinergic and purinergic responses in the rat urinary bladder. Eur J Pharmacol 428:357-364.
16. Gil D, Spalding T, Kharlamb A, Skjaerbaek N, Uldam A, Trotter C, Li D, WoldeMussie E, Wheeler L, Brann M (2001) Exploring the potential for subtype-selective muscarinic agonists in glaucoma. Life Sci 68:2601-2604.
17. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J (1999a) Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96:1692-1697.
18. Gomeza J, Zhang L, Kostenis E, Felder C, Bymaster F, Brodkin J, Shannon H, Xia B, Deng C, Wess J (1999b) Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96:10483-10488.
19. Goyal RK, Hirano I (1996) The enteric nervous system. N Engl J Med 334:1106-1115.
20. Hamilton SE, Loose MD, Oi M, Levey AI, Hille B, McKnight GS, Idzerda RL, Nathanson NM (1997) Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 94:13311-13316.
21. Hardman JG, Limbird LE, Gilman AG (2001) Goodman and Gilman's the pharmacological basis of therapeutics, Ed 10. New York: McGraw-Hill.
22. Holzer P, Holzer-Petsche U (1997) Tachykinins in the gut. I. Expression, release and motor function. Pharmacol Ther 73:173-217.
23. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC (1993) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286.
24. Ishiura Y, Yoshiyama M, Yokoyama O, Namiki M, de Groat WC (2001) Central muscarinic mechanisms regulating voiding in rats. J Pharmacol Exp Ther 297:933-939.
25. Ishizaka N, Noda M, Yokoyama S, Kawasaki K, Yamamoto M, Higashida H (1998) Muscarinic acetylcholine receptor subtypes in the human iris. Brain Res 787:344-347.
26. Jumblatt JE, Hackmiller RC (1994) M2-type muscarinic receptors mediate prejunctional inhibition of norepinephrine release in the human iris-ciliary body. Exp Eye Res 58:175-180.
27. Kotlikoff MI, Dhulipala P, Wang YX (1999) M2 signaling in smooth muscle cells. Life Sci 64:437-442.
28. Lepor H, Kuhar MJ (1984) Characterization of muscarinic cholinergic receptor binding in the vas deferens, bladder, prostate and penis of the rabbit. J Urol 132:392-396.
29. Matsui M, Araki Y, Karasawa H, Matsubara N, Taketo MM, Seldin MF (1999) Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes. Genes Genet Syst 74:15-21.
30. Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, Taketo MM (2000) Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 97:9579-9584.
31. O'Brien MD, Camilleri M, Thomforde GM, Wiste JA, Hanson RB, Zinsmeister AR (1997) Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Dig Dis Sci 42:26-33.
32. Parkman HP, Pagano AP, Ryan JP (1999a) Subtypes of muscarinic receptors regulating gallbladder cholinergic contractions. Am J Physiol 276:G1243-G1250.
33. Parkman HP, Trate DM, Knight LC, Brown KL, Maurer AH, Fisher RS (1999b) Cholinergic effects on human gastric motility. Gut 45:346-354.
34. Ponec RJ, Saunders MD, Kimmey MB (1999) Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 341:137-141.
35. Pontari MA, Luthin GR, Braverman AS, Ruggieri MR (1998) Characterization of muscarinic cholinergic receptor subtypes in rat prostate. J Recept Signal Transduct Res 18:151-166.
36. Ruwart MJ, Klepper MS, Rush BD (1979) Evidence for noncholinergic mediation of small intestinal transit in the rat. J Pharmacol Exp Ther 209:462-465.
37. Sawyer GW, Ehlert FJ (1998) Contractile roles of the M2 and M3 muscarinic receptors in the guinea pig colon. J Pharmacol Exp Ther 284:269-277.
38. Schmid SW, Modlin IM, Tang LH, Stoch A, Rhee S, Nathanson MH, Scheele GA, Gorelick FS (1998) Telenzepine-sensitive muscarinic receptors on rat pancreatic acinar cells. Am J Physiol 274:G734-G741.
39. Sharpe LG, Pickworth WB (1981) Pharmacologic evidence for a tonic muscarinic inhibitory input to the Edinger-Westphal nucleus in the dog. Exp Neurol 71:176-190.
40. Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
41. Stengel PW, Gomeza J, Wess J, Cohen ML (2000) M2 and M4 receptor knockout mice: Muscarinic receptor function in cardiac and smooth muscle in vitro. J Pharmacol Exp Ther 292:877-885.
42. Waxman I, Mathews J, Gallagher J, Kidwell J, Collen MJ, Lewis JH, Cattau Jr EL, al-Kawas FH, Fleischer DE, Benjamin SB (1991) Limited benefit of atropine as premedication for colonoscopy. Gastrointest Endosc 37:329-331.
43. Xu W, Gelber S, Orr-Urtreger A, Armstrong D, Lewis RA, Ou CN, Patrick J, Role L, De Biasi M, Beaudet AL (1999a) Megacystis, mydriasis, and ion channel defect in mice lacking the α3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 96:5746-5751.
44. Xu W, Orr-Urtreger A, Nigro F, Gelber S, Sutcliffe CB, Armstrong D, Patrick JW, Role LW, Beaudet AL, De Biasi M (1999b) Multiorgan autonomic dysfunction in mice lacking the β2 and the β4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci 19:9298-9305.
45. Yagi T, Ikawa Y, Yoshida K, Shigetani Y, Takeda N, Mabuchi I, Yamamoto T, Aizawa S (1990) Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc Natl Acad Sci USA 87:9918-9922.
46. Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, Wess J (2001a) Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 98:14096-14101.
47. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J (2001b) Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410:207-212.